HomeNDC LookupRxCUI directory › RxCUI 2635025

{28 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules) / 28 (ivacafto... — RxCUI 2635025

RxNorm drug concept · Generic pack
RxCUI 2635025 Generic pack · GPCK ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2635025
Official name{28 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules) / 28 (ivacaftor 75 MG Oral Granules) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)51,835 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ivacaftor: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Kalydeco doesn't cure cystic fibrosis, but it targets the root cause in people with certain gene mutations. It helps a faulty protein in your cells — called CFTR — work better by k...
  • What exactly does Kalydeco do for cystic fibrosis — does it cure it?
  • It really does matter what you take it with. Fat in food increases how much ivacaftor your body absorbs — by as much as 2.5 to 4 times. Taking it with just water means you're likel...
  • Why does it have to be taken with food? Can I just take it with water?
📖 Read our full Ivacaftor guide →

🕸️ Concept Web — How {28 (elexacaftor 100 MG / ivacaftor 75 MG / teza... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {28 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules) / 28 (ivacaftor 75 MG Oral Granules) } Pack RxCUI 2635025

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Elexacaftor 2256951
    • Ivacaftor 1243041
    • Tezacaftor 1999382
    • Elexacaftor / ivacaftor / tezacaftor 2257010
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kalydeco 1243047
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Elexacaftor / ivacaftor / tezacaftor Oral Granules 2635012
    • Ivacaftor Oral Granules 1606861
    • Elexacaftor / ivacaftor / tezacaftor Granule Product 2635011
    • Elexacaftor / ivacaftor / tezacaftor Oral Product 2257007
    • Ivacaftor Granule Product 1606860
    • Ivacaftor Oral Product 1243043
    • Ivacaftor Oral Granules [Kalydeco] 1606864
    • Kalydeco Granule Product 1606865
    • +4 more in this family
  4. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 21 of 25 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules SCD · 2635024
  • Ivacaftor 75 MG Oral Granules SCD · 1606868
  • Elexacaftor 100 MG SCDC · 2257006
  • Ivacaftor 75 MG SCDC · 1606867
  • Tezacaftor 50 MG SCDC · 2174386
  • Elexacaftor / ivacaftor / tezacaftor Oral Granules SCDF · 2635012
  • Ivacaftor Oral Granules SCDF · 1606861
  • Elexacaftor / ivacaftor / tezacaftor Granule Product SCDG · 2635011
  • Elexacaftor / ivacaftor / tezacaftor Oral Product SCDG · 2257007
  • Ivacaftor Granule Product SCDG · 1606860

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 2635025 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51167-0106-02 4 BLISTER PACK in 1 CARTON (51167-106-02) / 1 KIT in 1 BLIS... Trikafta Vertex Pharmaceuticals Incorporated 2021-06-08
51167-0331-01 4 BLISTER PACK in 1 CARTON (51167-331-01) / 1 KIT in 1 BLIS... Trikafta Vertex Pharmaceuticals Incorporated 2019-10-21
51167-0445-01 4 PACKAGE in 1 CARTON (51167-445-01) / 1 KIT in 1 PACKAGE *... Trikafta Vertex Pharmaceuticals Incorporated 2023-04-26
51167-0446-01 4 PACKAGE in 1 CARTON (51167-446-01) / 1 KIT in 1 PACKAGE *... Trikafta Vertex Pharmaceuticals Incorporated 2023-04-26
Observed labelers: Vertex Pharmaceuticals Incorporated (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.